CN1075167A - The manufacture method of mydecamycin - Google Patents

The manufacture method of mydecamycin Download PDF

Info

Publication number
CN1075167A
CN1075167A CN 93110080 CN93110080A CN1075167A CN 1075167 A CN1075167 A CN 1075167A CN 93110080 CN93110080 CN 93110080 CN 93110080 A CN93110080 A CN 93110080A CN 1075167 A CN1075167 A CN 1075167A
Authority
CN
China
Prior art keywords
mydecamycin
hours
propionic acid
acid amide
fermented liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93110080
Other languages
Chinese (zh)
Inventor
熊宗贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENYANG PHARMACY COLLEGE
Shenyang Pharmaceutical University
Original Assignee
SHENYANG PHARMACY COLLEGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENYANG PHARMACY COLLEGE filed Critical SHENYANG PHARMACY COLLEGE
Priority to CN 93110080 priority Critical patent/CN1075167A/en
Publication of CN1075167A publication Critical patent/CN1075167A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a kind of method of manufacture order component mydecamycin.In the fermention medium that produces bacterium change strain, add propionic acid amide, just can make the mydecamycin A in the product 1Content is improved significantly.The characteristics of this method are that technology is simple, and are reliable for effect.

Description

The manufacture method of mydecamycin
The present invention relates to a kind of fermentation process that propionic acid amide is produced mydecamycin that in fermention medium, adds.
Mydecamycin belongs to Macrolide polycomponent microbiotic, in respect of A 1, A 2, A 3, A 4Four components, as medicinal mainly be wherein A 1Component.China Ministry of Health regulation, the antibiotic major constituent content of the full biosynthesizing of single component should be not less than 80%.External mydecamycin is with the A in the kind 1The content majority is all more than 80%." mydecamycin " that China's bacterial strain is produced all is the polycomponent product for a long time, removes to contain a certain amount of A 1The leucomycin A that also has a great deal of outward, 6Etc. component.Unresolved for many years this problem causes China can only produce the polycomponent product, and this product is renamed as " Meleumycinum " (meleumycin), stipulates wherein A 1Content (external standard method) 35%, tire more than 850 μ g/mg.Leucomycin A 6To the antibiotic vigor of pathogenic bacterias such as golden Portugal bacterium 15, pneumococcus 31103 than mydecamycin A 1Little 2-4 doubly.Thereby the curative effect of Meleumycinum is affected.
Mydecamycin is the sixteen-ring macrolide antibiotic, contains aglycon, the mould aminosugar of carbon, three parts of mycaminose in its molecular structure.Because aglycon C 3-OH and mycaminose C 4 "The last acyl substituent difference of-OH can form different components.Mydecamycin A 1With leucomycin A 6Chemical structural formula be:
Figure 931100801_IMG2
Mydecamycin A 1Component R=COCH 2CH 3
Leucomycin A 6Component R=COCH 3
Mydecamycin A 1C 3Substituting group on the-OH is a propionyl, and leucomycin A 6It is ethanoyl.
Obtain the full biosynthesizing microbiotic of single component, can adopt the gene that change antibiotics generated bacterium, improve the method for precursor output; Also can adopt the method that in fermention medium, directly adds precursor substance.Do not see the biology of manufacture order component mydecamycin or the report of producing and manufacturing technique so far as yet.
The object of the present invention is to provide a kind of method of producing mydecamycin, synthesize mydecamycin A as precursor substance with propionic acid amide 1Novel process.
The present invention is according to the biosynthesizing principle of wheat enlightening (in vain) mycin, the raising mydecamycin A that designs 1This method of output.In the fermention medium that produces bacterium change strain, add propionic acid amide, the mydecamycin A in the fermented liquid 1Content just improves the 10-40%(area normalization method than the reference substance that does not add propionic acid amide), A 1Increasing amount relevant with the add-on and the joining day of propionic acid amide.
As shown in table 1, Streptomyces Macrofaciens 1748 becomes strains in shaking bottle shaking culture, at different fermentation times, the aseptic propionamide solution that adds 100-300mg% in fermention medium, the mydecamycin A in the fermented liquid 1All increases of showed different of content, added at 12 hours especially, increase the most obvious.
Figure 931100801_IMG3
Annotate: testing used fermention medium is starch 1.0%, sucrose 4.0%, analysis for soybean powder 3.0%, fish meal 0.2%, yeast powder 0.2%, potassium primary phosphate 0.1%, sal epsom 0.1%, lime carbonate 0.15%.The 250ml triangular flask, loading amount 20ml, the seed of access Streptomyces Macrofaciens, in 28 ℃, shaking culture 2 days adds the different propionic acid amide sterilized solutions of measuring at different incubation times.After the cultivation, through centrifugation, supernatant liquor send the high pressure liquid phase analysis component.
The object of the present invention is achieved like this: Streptomyces Macrofaciens 1748 is become strain (Streptomyces mycarofaciens var.1748) earlier in sterilization, cooled seed culture medium (consisting of glucose, starch, analysis for soybean powder, ammonium sulfate, potassium primary phosphate, lime carbonate), cultivated 48 hours, and promptly got the seed liquor that produces bacterium for 28 ℃;
Seed liquor with gained, change in sterilization, the cooled fermention medium (consisting of glucose, starch, analysis for soybean powder, yeast powder, sal epsom, potassium primary phosphate, lime carbonate) by 15% inoculum size, 28 ℃ of aeration-agitations are cultivated, in fermentation 24 hours, gradation adds the aseptic propionamide solution that its total amount is 0.1-0.8%, cultivated 48 hours, and promptly got fermented liquid.
The gained fermented liquid is handled routinely, and filtration, extraction, crystallization, drying promptly get the mydecamycin finished product.
Advantage of the present invention is: utilizing the component of the mydecamycin product of described method production, almost mainly is mydecamycin A 1, content reaches the 80%(external standard method) more than, and do not add the A of the experimental control product of propionic acid amide 1Content only is about 50%.This is very favorable from the industrial production angle.The characteristics of this method are that technology is simple, reliable for effect.
Embodiment 1:
Streptomyces Macrofaciens 1748 becomes strain, in the aseptic seed substratum of seeding tank, cultivates 48 hours for 28 ℃ earlier.Seed culture medium consist of glucose 3.0%, starch 1.0%, analysis for soybean powder 2.0%, ammonium sulfate 0.5%, potassium primary phosphate 0.05%, lime carbonate 0.3%.The gained seed culture fluid changes the 300l that is contained in the 500l fermentor tank over to by 15% inoculum size not to be had in the bacteria fermentation culture medium.Fermention medium consist of glucose 1.0%, starch 3.0%, analysis for soybean powder 3.0%, yeast powder 0.2%, sal epsom 0.1%, potassium primary phosphate 0.1%, lime carbonate 0.1%.Carry out aeration-agitation at 28 ℃ and cultivate, air flow is 1vvm, and mixing speed is 250r.p.m, cultivates 48 hours, just makes the mydecamycin fermented liquid.
In culturing process,, add 0.1%, 0.2% the propionic acid amide solution that bacterium is crossed in death of monks or nuns respectively in fermentation initial sum in the time of 12 hours.The fermentation unit of fermentation termination for do not add propionic acid amide control fermentation liquid fermentation unit 90%.
The fermented liquid of gained is handled through routine, and filtration, extraction, crystallization, drying promptly get the mydecamycin product.Mydecamycin A in the product 1Content reaches the 84%(external standard method), tiring, to reach 980 μ g/mg(be test organisms with the Bacillus subtilus), and do not add the A of the experimental control product of propionic acid amide 1Content is 53.8% only, and tiring is 910 μ g/mg.
Embodiment 2:
The composition of seed culture medium and fermention medium is with embodiment 1.In the 500l fermentor tank, the 300l fermention medium of packing into after the sterilization cooling, inserts the seed culture fluid that Streptomyces Macrofaciens 1748 becomes strain, and mixing speed is 250r.p.m., and air flow is 1vvm, cultivates 48 hours in 28 ℃ of aeration-agitations, promptly gets the mydecamycin fermented liquid.
In culturing process,, add 0.05%, 0.1% the propionic acid amide solution that bacterium is crossed in death of monks or nuns respectively in fermentation initial sum in the time of 12 hours.Consequently, fermentation unit for do not add propionic acid amide contrast 95%, the mydecamycin A in the product 1Content reaches 81%, tires to reach 950 μ g/mg, and does not add the A of the experimental control product of propionic acid amide 1Content is 51.9%, and tiring is 905 μ g/mg.
Embodiment 3:
Seed culture medium and the composition of sending out substratum pure are with embodiment 1.In the 500l fermentor tank, the 300l fermention medium of packing into after the sterilization cooling, inserts the seed culture fluid that Streptomyces Macrofaciens 1748 becomes strain, and mixing speed is 250r.p.m., and air flow is 1vvm, cultivates 48 hours in 28 ℃ of aeration-agitations, promptly gets the mydecamycin fermented liquid.
In culturing process,, add 0.1%, 0.3% the propionic acid amide solution that bacterium is crossed in death of monks or nuns respectively in fermentation initial sum in the time of 20 hours.Consequently, fermentation unit for do not add propionic acid amide contrast 96%, the mydecamycin A in the product 1Content reaches 82%, tires to reach 955 μ g/mg, and does not add the A of the experimental control product of propionic acid amide 1Content is 52.4%, and tiring is 910 μ g/mg.

Claims (1)

1, a kind of production chemical structural formula is
Figure 931100801_IMG1
The method of mydecamycin is characterized in that:
A. Streptomyces Macrofaciens 1748 is become strain (Streptomycesmycarofaciensvar.1748) in seed culture medium, cultivated 48 hours, and promptly got the seed liquor that produces bacterium for 28 ℃;
B. with the seed liquor of gained, change in the fermention medium by 15% inoculum size, 28 ℃ of aeration-agitations are cultivated, and in fermentation 24 hours, gradation adds the aseptic propionamide solution that its total amount is 0.1-0.8%, cultivates 48 hours, promptly gets fermented liquid;
C. the gained fermented liquid is handled routinely, filtration, extraction, crystallization, drying are finished product.
CN 93110080 1993-02-12 1993-02-12 The manufacture method of mydecamycin Pending CN1075167A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93110080 CN1075167A (en) 1993-02-12 1993-02-12 The manufacture method of mydecamycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93110080 CN1075167A (en) 1993-02-12 1993-02-12 The manufacture method of mydecamycin

Publications (1)

Publication Number Publication Date
CN1075167A true CN1075167A (en) 1993-08-11

Family

ID=4987988

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93110080 Pending CN1075167A (en) 1993-02-12 1993-02-12 The manufacture method of mydecamycin

Country Status (1)

Country Link
CN (1) CN1075167A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094979C (en) * 1996-02-09 2002-11-27 吉斯特·布罗卡迪斯股份有限公司 Natamycin recovery
CN102532222A (en) * 2010-12-21 2012-07-04 北大方正集团有限公司 Catalyzing method of medecamycin
CN102676617A (en) * 2011-03-17 2012-09-19 河南天方药业股份有限公司 Preparation method for meleumycin
CN108977481A (en) * 2017-11-08 2018-12-11 北大方正集团有限公司 A kind of method of fermenting and producing meleumycin

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094979C (en) * 1996-02-09 2002-11-27 吉斯特·布罗卡迪斯股份有限公司 Natamycin recovery
CN102532222A (en) * 2010-12-21 2012-07-04 北大方正集团有限公司 Catalyzing method of medecamycin
CN102532222B (en) * 2010-12-21 2015-06-17 北大方正集团有限公司 Catalyzing method of medecamycin
CN102676617A (en) * 2011-03-17 2012-09-19 河南天方药业股份有限公司 Preparation method for meleumycin
CN108977481A (en) * 2017-11-08 2018-12-11 北大方正集团有限公司 A kind of method of fermenting and producing meleumycin
CN108977481B (en) * 2017-11-08 2021-08-27 北大方正集团有限公司 Method for producing meleumycin by fermentation

Similar Documents

Publication Publication Date Title
US4529797A (en) Heteropolysaccharide S-198
IL102731A (en) Fermentation process for producing natamycin
CN1075167A (en) The manufacture method of mydecamycin
CN102220396A (en) Simple fermentation method for acarbose
CN1480524A (en) Method for preparing astaxanthin from alga cultivated by using residue of fermenting yeast
CN116478865A (en) Fermentation medium and fermentation method for increasing yield of avermectin
CN111303248B (en) Material supplementing method for improving teicoplanin fermentation yield
CN1891834A (en) Fermenting method for producing natamycin
FI110518B (en) Levan sucrose enzyme, process for its preparation, microorganisms producing it and compositions containing it
EP1613759B1 (en) Fermentation processes with low concentrations of carbon- and nitrogen-containing nutrients
Trück et al. A study of N-and P-dependence of nikkomycin production in continuous culture with immobilized cells
CN114875100B (en) Method for improving fermentation yield of natamycin by activating natamycin synthesis in advance
CN1053697C (en) Fermentation method for producing D-ribose novel strain, and method for prepn. of D-ribose using said strain
CN114381418B (en) Fermentation medium for improving fermentation unit of apramycin and application of fermentation medium
CN1306091A (en) Bacterial fermentation process for preparing L-lactic acid
CN114381384B (en) Seed culture medium for improving apramycin fermentation unit and application thereof
US4275155A (en) Manufacture of aminoglycoside antibiotics
CN1221031A (en) Continuous transfer new technology for microbe industrial fermentation
CN1224696C (en) Fungus bacterial culture medium
KR900000525B1 (en) Process for preparing gentamycin by fermentation
CN101260393A (en) Method for producing keratinase by liquid deep fermentation
CN1393564A (en) Process for preparing citric acd by fermentation and bacterial strain for it
US3853991A (en) Antibiotic axenomycine and method for the preparation thereof
CN117089589A (en) Method for producing erythromycin thiocyanate by fermentation
CN1193048A (en) Method for producing beta-carotene by fermentation

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication